Publications by authors named "Frederic Pinguet"

Claim this Profile
[
[Early non-compliance with oral anticancer drugs, a clinical pharmacy as key issue in onco-senology].
Fanny Leenhardt, Pauline Ares, Alma Nicolai, Cécile Corbinais, Marie Viala, Frédéric Pinguet

Therapie· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral targeted therapy dose adaptation in older patients with cancer: A real-life French cohort.
Clément Carbasse, Fanny Leenhardt, William Jacot, Caroline Perrier, Frederic Pinguet

Br J Clin Pharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced -Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management.
Isabelle Solassol, Frédéric Pinguet, Xavier Quantin

Biomolecules· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New advances in DPYD genotype and risk of severe toxicity under capecitabine.
Marie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Christophe Beroud, Litaty Mbatchi, André van Kuilenburg, Frédéric Pinguet

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacist involvement in supporting care in patients receiving oral anticancer therapies: A situation report in French cancer centers].
Sandrine Occhipinti, Emilie Petit-Jean, Frédéric Pinguet, Cécile Beaupin, Mikaël Daouphars

Bull Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.
Mélodie Dell'Ova, Eléonora De Maio, Séverine Guiu, Lise Roca, Florence Dalenc, Frédéric Pinguet

BMC Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter prospective observational study of the conformity of temozolomide prescriptions in France.
Patrick Tilleul, Melanie Brignone, Yasmine Hassani, Christelle Labrande, Stéphane Pedeboscq, Frederic Pinguet

Pharmacoepidemiol Drug Saf· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.
Pierre-Emmanuel Colombo, Mahfoud Boustta, Sylvain Poujol, Marta Jarlier, Françoise Bressolle, Frederic Pinguet

Gynecol Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and pharmacokinetics of EAPB0203 and EAPB0503, two imidazoquinoxaline compounds previously shown to have antitumoral activity on melanoma and T-lymphomas.
Sonia Khier, Florence Gattacceca, Safia El Messaoudi, Florian Lafaille, Carine Deleuze-Masquéfa, Frédéric Pinguet

Drug Metab Dispos· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure.
Antonin Schmitt, Laurence Gladieff, Céline M Laffont, Alexandre Evrard, Jean-Christophe Boyer, Frédéric Pinguet

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma.
Sonia Khier, Carine Deleuze-Masquéfa, Georges Moarbess, Florence Gattacceca, Delphine Margout, Frédéric Pinguet

Eur J Pharm Sci· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags.
Céline Eiden, Laurent Philibert, Khedidja Bekhtari, Sylvain Poujol, Francoise Malosse, Frédéric Pinguet

Am J Health Syst Pharm· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Carine Deleuze-Masquefa, Georges Moarbess, Sonia Khier, Nadège David, Stéphanie Gayraud-Paniagua, Frédéric Pinguet

Eur J Med Chem· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model.
Virginie Charasson, Dominique Hillaire-Buys, Isabelle Solassol, Armelle Laurand-Quancard, Frédéric Pinguet

Eur J Cancer· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MS.
Sonia Khier, Georges Moarbess, Carine Deleuze-Masquefa, Isabelle Solassol, Delphine Margout, Frédéric Pinguet

J Sep Sci· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
Antonin Schmitt, Laurence Gladieff, Amélie Lansiaux, Christine Bobin-Dubigeon, Marie-Christine Etienne-Grimaldi, Frédéric Pinguet

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPLC with UV or mass spectrometric detection for quantifying endogenous uracil and dihydrouracil in human plasma.
Rūta Svobaite, Isabelle Solassol, Frederic Pinguet, Liudas Ivanauskas, Janine Brès

Clin Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
Georges Moarbess, Carine Deleuze-Masquefa, Vanessa Bonnard, Stéphanie Gayraud-Paniagua, Jean-Rémi Vidal, Frédéric Pinguet

Bioorg Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer.
Jean Pierre Delord, Florence Dalenc, Frédéric Pinguet, Laurent Nguyen, Isabelle Lochon

Oncology· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A limited sampling strategy to estimate the pharmacokinetic parameters of irinotecan and its active metabolite, SN-38, in patients with metastatic digestive cancer receiving the FOLFIRI regimen.
Sylvain Poujol, Frederic Pinguet, Marc Ychou, Anissa Gauthey Abderrahim, Jacqueline Duffour

Oncol Rep· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers.
Stéphane Culine, Mounira El Demery, Pierre-Jean Lamy, François Iborra, Christophe Avancès, Frédéric Pinguet

J Urol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of indoloquinolines and pyridocarbazoles: a new example of unexpected photoreduction accompanying photocyclization.
Pierre-Jean Aragon, Ange-Désiré Yapi, Frédéric Pinguet, Jean-Michel Chezal, Jean-Claude Teulade

Chem Pharm Bull (Tokyo)· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.
Jacqueline Duffour, Sophie Gourgou, Françoise Desseigne, Charles Debrigode, Laurent Mineur, Frédéric Pinguet

Cancer Chemother Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration.
Pierre-Emmanuel Colombo, Mahfoud Boustta, Sylvain Poujol, Frédéric Pinguet, Philippe Rouanet

Eur J Pharm Sci· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro cytotoxic effect of melphalan and pilot phase II study in hormone-refractory prostate cancer.
Philippe Mougenot, Françoise Bressolle, Stéphane Culine, Isabelle Solassol, Sylvain Poujol, Fréderic Pinguet

Anticancer Res· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis